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Abstract.  We report that gene dosage, or the ratio of 
nuclei from two cell types fused to form a heterokar- 
yon, affects the time course of differentiation-specific 
gene expression. The rate of appearance of the human 
muscle antigen, 5.1H 11, is significantly faster in heter- 
okaryons with equal or near-equal numbers of mouse 
muscle and human fibroblast nuclei than in hetero- 
karyons with increased numbers of nuclei from either 
cell type. By 4 d after fusion, a high frequency of gene 
expression is evident at all ratios and >75% of hetero- 
karyons express the antigen even when the nonmuscle 
nuclei greatly outnumber the muscle nuclei. The ki- 
netic differences observed with different nuclear ratios 
suggest that the concentration of putative trans-acting 
factors significantly influences the rate of muscle gene 
expression: a threshold concentration is necessary, but 
an excess may be inhibitory. 
elucidation of the mechanisms that regulate changes 
in  gene  expression  is  of central  importance to  an 
understanding of the development of complex mul- 
ticellular eukaryotes. Cellular differentiation does not appear 
to be due to loss of genomic material (9,  11, 21). Instead, to 
generate and maintain the specialized characteristics of cells 
of  differentiated tissues, genes must be activated and repressed 
in an  orderly fashion. There are some indications that the 
differential regulation of genes is mediated by the interaction 
of specific trans-acting factors with  cis-acting genomic se- 
quences, such as promoters and enhancers (4). Although the 
mechanism of  action of  certain general mediators of  transcrip- 
tion has been demonstrated to be concentration dependent 
(16,  17, 19, 22, 29, 30), relatively little is known regarding the 
amounts required for tissue-specific  gene expression in mam- 
malian cells. 
Experiments with somatic cell hybrids suggested that tissue- 
specific trans-acting molecules might play a role in the expres- 
sion of differentiated functions in mammalian cells. This is 
now known to be true from studies of  the expression of  certain 
cloned genes following transfection. Cell fusion results in the 
combination of the entire genomes and cytoplasms of two 
cells  of different functional states.  This leads either to  the 
repression of  the differentiated functions of  the expressing cell 
type or to the activation of silent genes in the non-expressing 
cell type. The different outcomes obtained with hybrids are 
correlated with gene dosage,  or the relative ratio of the chro- 
mosomes  contributed  by  each  of the  parental  cell  types. 
Repression is typically observed with equivalent gene dosage 
or with increased genetic input from the non-expressing cell 
type; activation  is  usually detected only when  the  genetic 
input from the expressing cell type is increased (for review see 
references 10, 20, 28). However, a limitation of such studies 
is that the initial fusion products can rarely be analyzed for 
more than short periods of time after their production; cell 
division  and  chromosome loss  and  rearrangement  rapidly 
ensue.  Consequently, a  kinetic analysis of the  influence of 
gene dosage on gene expression is not possible. 
To examine concentration requirements in the activation 
and  expression  of differentiation-specific eukaryotic  genes 
over time,  we  have  used  a  stable  heterokaryon system  in 
which  cell  division  does  not  occur.  Gene  dosage  can  be 
manipulated in these heterokaryons by altering the ratio of 
intact nuclei so that the normal location of genes within the 
genome and the stoichiometry between regulatory and struc- 
tural genes per nucleus are maintained. The detailed kinetic 
analysis of the relationship between nuclear ratio and gene 
expression presented here is possible because the initial fusion 
product, a heterokaryon, survives for up to 2 wk in culture. 
We have previously shown that when mouse muscle cells are 
fused with human fibroblasts to form heterokaryons, human 
muscle genes are activated. The expression of genes coding 
for seven diverse functions is detected: a cell surface compo- 
nent (5.1HI 1),  an  enzyme essential  for energy production 
(creatine kinase), and five structural proteins of  the contractile 
apparatus (actins and  myosin light chains) (1,  2,  6,  7,  12). 
Furthermore, the frequency and efficiency ofgene activation 
is high; 95 ___ 1% of all heterokaryons express human muscle 
genes and the relative amounts of the muscle gene products 
are typical of pure muscle cultures. Examples of gene repres- 
sion and activation using similar muscle heterokaryons have 
been reported by others (14, 31, 32). 
We show here that regardless of nuclear ratio, muscle gene 
activation is  observed; nuclear ratio,  however, significantly 
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ences  in  rates,  the  ultimate  efficiency of gene  activation 
reaches  a  high  level  of >75%  at  all  nuclear  ratios.  These 
results indicate that muscle gene activation does not require 
increased muscle gene dosage; given sufficient time, a single 
muscle nucleus can activate muscle genes in heterokaryons 
containing as many as six fibroblast nuclei. We interpret these 
results to mean that the expression of muscle genes requires 
activators  and  does  not  result  simply  from  a  dilution  of 
repressors. A particularly unexpected finding is that the most 
rapid accumulation of human muscle-specific proteins is ob- 
served in heterokaryons with equivalent muscle to nonmuscle 
ratios; increased nuclear input from either cell type results in 
slower kinetics. Thus, the accumulation of muscle gene prod- 
ucts  is  slower when  the  muscle  nuclei  in  a  heterokaryon 
outnumber the fibroblast nuclei; a relative increase in muscle 
genes has a negative effect. These results are compatible with 
the  hypothesis that  the  rate  of muscle gene  expression  in 
heterokaryons is dependent on the concentration or stoichi- 
ometry of muscle trans-acting factors: a threshold concentra- 
tion is required, but increased amounts are inhibitory. 
Materials and Methods 
Cell Culture and Heterokaryon Production 
Mouse muscle cells, C2Ct2, were a diploid subclone isolated in our laboratory 
from  the  C2  cell  line  generously provided  by  Dr.  David  Yaffe  (33)  and 
karyotyped in our laboratory. Human fibroblasts were a diploid strain isolated 
from  fetal lung (MRC-5)  (13).  Heterokaryons were produced by fusing my- 
otubes and fibroblasts with polyethylene glycol (PEG) (1).  Briefly, the cultures 
were  treated  with PEG  1000  (50%  wt/vol in  Dulbecco's modified  Eagle's 
medium), pH 7.4 for 60 s at 37"C, and then rinsed with Dulbecco's modified 
Eagle's medium three times in succession for 60 s each. To remove unfused 
cells, the selective agents, cytosine arabinoside (10  -5 M), and ouabain ( 10  -~ M), 
were routinely added. Cytosine arabinoside inhibits DNA synthesis and kills 
dividing cells (8); ouabain inhibits Na+-K  ÷ ATPase and has a  100-fold greater 
affinity for the human than the rodent enzyme (23). To distinguish mouse and 
human nuclei, heterokaryons were stained after fixation with Hoechst 33258 
(Riedel-de Haen, Hanover, Germany), 0.12 #g/ml in 0.9% NaCI for 15 min at 
37"C as previously described (1). The proportion of heterokaryons with a given 
nuclear composition (muscle:nonmuscle) was consistent among experiments: 
1:>2 (R --.  I%),  1:2 (17 --4=- 1%),  1:1 (33 --. 3%), 2:1 (23 --. 2%), >2:1 (19 _+ 2%). 
Assays for 5.1Hll Expression 
The monoclonal antibody, 5. I HI 1, generously provided by Dr. Frank Walsh 
(23, 24) recognizes the human muscle-specific cell surface antigen, but not its 
mouse muscle counterpart (6).  Assays for the expression of this antigen were 
as previously described (7).  Briefly, live cells were  incubated at  37"C  with 
5. I H 11 antibody either in undiluted hybridoma supernatant or in mouse aseites 
fluid, washed, incubated with a second horse anti-mouse antibody conjugated 
to  biotin  (Vector  Laboratories,  Inc.,  Burlingame,  CA),  washed  again,  and 
incubated with avidin conjugated to  Texas  Red  (Zymed  Laboratories,  San 
Francisco, CA). Stained cells were fixed sequentially in  1% formalin at 37"C 
and  100%  methanol at -20"C.  Specificity of binding was determined by the 
lack of fluorescence when parallel dishes were exposed either to second antibody 
only, to mouse gamma globulin (25 #g/ml) partially  purified from non-immune 
ascites fluid, or  to  undiluted supernatant  of a  monoclonal antibody which 
recognizes a neuronal antigen. 
Kinetic Analyses and Statistics 
The data were pooled into five groups of muscle:nonmuscle nuclear ratios 1: 
>2; l:x where 1 <x_  <  2; l:l;x:.l where 1 <x-<-2; and >2:1. 
To  facilitate comparison  of the  overall  kinetics of gene  expression  for 
heterokaryons of different nuclear composition, the t~o was determined. The t~o 
is the time required after fusion for half of the heterokaryons to express the 
antigen,  5.1HI 1.  To  determine the  t~o, a  curve-fitting program was used to 
analyze the time course of 5.1HII  expression by heterokaryons of different 
nuclear composition.  The  proportion  of total heterokaryons expressing the 
antigen on day 6 was designated 100% for each pooled ratio and the frequencies 
obtained on earlier days for these ratios were normalized to the day 6  values. 
Using Marquardt's least squares analysis, a  number of equations were tested 
for goodness of fit. The one which fit the data best was y  =  100 -  ae-b% an 
equation  depicting first  order  kinetics.  The  significance of the  differences 
between curves for different nuclear ratios was determined by comparing the 
coefficients a and b using the Student's t test. 
Error bars  on  histograms indicate the  standard  error  of the  proportion 
calculated  from  the  standard  binomial  equation:  p~q/n.  Where  error 
bars do not overlap, differences are significant at the 0.05 level using a  two- 
sample Student's t test. 
Results 
Nuclear Ratio and Kinetics of Gene Expression 
We examined the influence  of nuclear ratio on the rate of 
expression  of a  human  muscle gene.  Heterokaryons were 
produced by fusing mouse muscle cells (C2C,2) with human 
lung fibroblasts (MRC-5)  using  polyethylene glycol (PEG). 
Heterokaryons were identified by the species-specific fluores- 
cent staining pattern of the muscle (mouse) and nonmuscle 
(human) nuclei they contained using the dye Hoechst 33258 
(1) (see also Fig.  1). This permitted a precise determination 
of the number of each type of nucleus present in individual 
heterokaryons. The expression of  a human muscle cell surface 
antigen  was  monitored  in  the  same heterokaryons using a 
monoclonal antibody 5.1Hll  (26,  27) detectable by fluores- 
cence  microscopy at a  different wavelength.  The  antibody 
recognizes an antigen present on human muscle membranes 
which is both species- and cell type-specific. We have dem- 
onstrated  previously that  the  expression  of this  antigen  is 
induced  in  the  nuclei  of lung fibroblasts after fusion  with 
mouse  muscle  cells  to  form  heterokaryons  (6).  Since  the 
antigen was never detected in either parental cell type alone, 
this expression was the result of gene activation. 
Heterokaryons were produced at low density in replicate 
dishes which were scored at seven successive time intervals 
for the expression of the antigen and for nuclear composition. 
The frequency of expression of 5.1H 11  was determined for 
up to 6 d after fusion. This was possible since the heterokar- 
yons were stable; nuclear or cell  division was not observed 
even  when  nonmuscle  nuclei  were  present  in  excess.  The 
results presented in Fig. 2 are a composite of  the data obtained 
in  19  independent  experiments in  which  a  total  of 2,684 
individual  heterokaryons were  analyzed.  The  frequency of 
heterokaryon production was high; 85 _  2% of all multinu- 
cleated cells contained both mouse and human  nuclei and 
heterokaryons with a broad spectrum of nuclear ratios were 
obtained. For analyses of kinetics, heterokaryons were pooled 
into  five groups according to nuclear ratio,  or the  relative 
number of muscle to nonmuscle nuclei they contained:  1  :>2, 
1:2,  1:1, 2:1,  and >2:1.  Consequently, each ratio included a 
range of nuclear numbers.  For example, the  1:2  group in- 
cluded beterokaryons with one muscle and two nonmuscle 
nuclei,  those  with  two  muscle and  four nonmuscle nuclei, 
and those with two muscle and three nonmuscle nuclei (see 
Materials and Methods). The proportion of heterokaryons of 
each ratio that expressed the antigen was determined at each 
time point. 
All heterokaryons of a given ratio do not express the antigen 
at the same time. For example, for nuclear ratio I:1, 38% of 
heterokaryons expressed the  antigen  at  1.5  d  after fusion, 
whereas 84% expressed the antigen at 3 d. This difference in 
the timing of expression of the  antigen on the cell surface 
125  Pavlath and Blau Gene Dosage and Kinetics of  Muscle Gene Expression Figure  I.  Expression  of human muscle gene 5.1HI 1 in a single heterokaryon. The multinucleated cell shown  in phase-contrast microscopy 
(top) is revealed by Hoechst fluorescence (middle)  to be a heterokaryon containing one punctate muscle nucleus (mouse) and five uniformly 
stained nonmuscle nuclei (human), or a nuclear ratio of 1:5. Immunofluorescence (bottom)  using a monoclonal antibody, 5.1H 11, followed by 
biotinylated anti-mouse antibody and Texas Red-avidin reveals the newly synthesized  human muscle antigen distributed along the length of 
the cell. Bar, 20 um. 
could be due to heterogeneity within the muscle cell popula- 
tion  at  the  time  of fusion.  The  C2Ct2  cells  used  in  these 
experiments, like most muscle cell lines and primary muscle 
cells, differentiate in a  stochastic manner (18).  If the muscle 
cells constituted a  spectrum  of differentiation stages which 
differed in the amount of  regulatory molecules they contained, 
the observed asynchronous expression of the antigen for each 
nuclear ratio would be expected. Alternatively, the difference 
in timing could be due to heterogeneity within the fibroblast 
population. These cells had a doubling time of 25 h and were 
in different phases of the cell cycle at the time of fusion. 
From the histograms in Fig. 2, it was evident that nuclear 
ratio  influenced the  kinetics with  which  heterokaryons ex- 
pressed the  human  muscle antigen.  As early as  1.5  d  after 
fusion, a difference in the proportion of heterokaryons exhib- 
iting activation was observed; nearly 40% of heterokaryons of 
The Journal of  Cell  Biology,  Volume 102, 1986  126 Figure 2 . Time-course of 5 .1H11 expression in heterokaryons of different nuclear ratios . Individual heterokaryons were analyzed for nuclear
composition and the expression of 5 .1 H I I between I and 6 d after PEG fusion . For purposes of comparison, the data were pooled into the five
indicated groups of muscle:nonmuscle nuclear ratios. The expression of5 .1H I I was first detected after a lag of - 1 d . Each bar ofthe histogram
represents the data derived from between 31 and 236 heterokaryons, with a mean of 89 ± 9 . Error bars indicate the standard error of the
proportion calculated from the standard binomial equation . Where error bars do not overlap, differences are significant at the 0.05 level using
a two-sample Student's t test.
nuclear ratio 1 :1 expressed the antigen as compared to -20%
of those of muscle to nonmuscle ratio 1 :>2 or >2:1 . Signifi-
cant differences in the frequency of expression of the antigen
persisted at 3 d . By 4 and 6 d after fusion, a high frequency
of>75% was observed for heterokaryons of all ratios . These
resultswere highly reproducible; they were obtained in several
independent experiments which were performed at different
times and used different passages of cells. Thus, at a nuclear
ratio of 1 :1 and even when muscle nuclei were greatly out-
numbered by fibroblast nuclei, the fibroblast gene coding for
the muscle antigen was activated. However, the ultimate
efficiency was consistently reduced when the proportion of
fibroblasts was increased (1 :>2): 75% as compared to >95%
for all other nuclear combinations . These results demonstrate
that although nuclear ratio does not determine whether a
heterokaryon will express the antigen, it does affect the rate
of antigen appearance . The fastest kinetics are observed with
equivalent, or near-equivalent nuclear input from the two cell
types . The slowest kinetics are observed when the relative
contribution of nuclei of one type, muscle or nonmuscle, is
increased .
The reduction in the rate ofexpression of the antigen when
either nonmuscle or muscle nuclei are present in excess is
more clearly demonstrated in Fig. 3 . The best fit lines for the
data presented in Fig. 2 are shown . A lag period of - 1 d
preceded the detection ofthe 5 .1H11 antigen in heterokaryons
regardless of nuclear ratio (Fig . 3, a and b) . This lag presum-
ably reflects the time required to synthesize and accumulate
sufficient antigen on the cell surface to be detectable by
immunofluorescence . Consequently, the lag includes the time
required for activation and transcription of the gene as well
as translation and processing of its product via the cell secre-
tory apparatus. Although the day 1 results in the histogram
in Fig. 2 suggest differences in the lag among heterokaryons
ofdifferent nuclear ratios, these differences are not definitive,
since the lag was not studied with precision : time intervals of
<12 h were not analyzed . Following the lag, the proportion
of heterokaryons expressing the antigen gradually increased
24 48 72 96 120 144
Hours after Fusion
Figure 3 . Effect of nuclear ratio on the kinetics of5 .1H 11 expression .
The mean ± standard error of the proportion (see Materials and
Methods) are shown for each time point for (A) increased nonmuscle
(1:>2) and (B) increased muscle (>3:1) . The values are compared
with those for a nuclear ratio of 1 :1 . Increased proportions of nuclei
of either cell type results in a decreased rate of accumulation of
5 .1H 11 . Where error bars do not overlap, differences are significant
at the 0.05 level using a two-sample Student's t test.
over a 5-d period . The slopes ofthe curves fordifferent pooled
ratios revealed that the relative input of nonmuscle and
muscle nuclei in heterokaryons significantly influenced the
rate of antigen appearance ; with either increased nonmuscle
or increased muscle nuclei, the kinetics of antigen expression
were slower.
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We examined the possibility that the differences in the kinetics 
of gene expression observed with different nuclear ratios were 
due to differences in total nuclear number and consequently 
heterokaryon size. The size of a heterokaryon could theoreti- 
cally influence the potential to detect the antigen, since more 
antigen might be required for visualization in a greater surface 
area.  The pooled  nuclear ratios analyzed in  Figs.  2  and  3 
included heterokaryons with a broad range in the total num- 
ber of nuclei they contained. To examine the possibility that 
heterokaryon size might influence the analysis of the kinetics 
ofgene expression, heterokaryons in groups containing equiv- 
alent  total  numbers  of nuclei  in  different  proportions  of 
muscle and nonmuscle were compared. As shown in Table I, 
we grouped all heterokaryons with four nuclei as follows: (A) 
2 muscle +  2 nonmuscle, (B) 3 muscle +  1 nonmuscle, and 
(C) 1 muscle + 3 nonmuscle. The kinetic curves and tso values 
were determined for each group. Although the nucleus/sur- 
face area ratio appeared to be similar for all three groups, the 
group of heterokaryons with equivalent numbers of muscle 
and nonmuscle nuclei (2  +  2) exhibited significantly faster 
kinetics of 5.1H 11 expression (P <  0.05). 
A  similar result was obtained for heterokaryons grouped 
according to the ratio of nuclei (Table I). These heterokaryons 
contained between 2 and 20 nuclei, and consequently, a range 
of cell  sizes.  For example, 74%  of the  heterokaryons with 
equivalent muscle and  nonmuscle nuclei,  i.e.,  of 1:1  ratio, 
were  binucleate.  A  comparison  of the  tso  values for these 
heterokaryons with primarily two nuclei and those of Group 
A with four nuclei revealed no significant difference (38 and 
40 h, respectively). We conclude that the ts0 values differ due 
to  relative nuclear  input,  not  absolute  nuclear  number  or 
heterokaryon size.  Moreover, we have determined that the 
more muscle nuclei a heterokaryon contains, the less diffuse 
and more localized is the  5.1 H11  antigen in the vicinity of 
the human nucleus responsible for its production (Pavlath, 
G. K., and H. M.  Blau,  manuscript in  preparation). Thus, 
5.1Hll  is  readily  detectable  even  in  large  multinucleated 
heterokaryons. We conclude that the differences in the rates 
of accumulation of muscle gene products reflect differences 
due to nuclear ratio, rather than limited detection due to cell 
size. 
Nuclear Position and Kinetics of Gene Expression 
We examined whether the position of the human nonmuscle 
nucleus relative to the muscle nuclei within a heterokaryon 
influenced either the rate or the ultimate potential to express 
the human muscle antigen,  5.1H11.  For this purpose, only 
heterokaryons containing a  single  nonmuscle nucleus were 
analyzed to ensure that the expression of 5.1H 11 could only 
have resulted from the activation of that nucleus. A total of 
512  heterokaryons with  a  single  nonmuscle  nucleus  were 
separated into  two groups:  those bordered unilaterally and 
those bordered bilaterally by muscle nuclei. As shown in Fig. 
4, the frequency of gene expression in these groups of heter- 
okaryons was analyzed as a function of time after heterokar- 
yon production. The results indicate that the position of the 
nonmuscle nucleus relative to the muscle nuclei in a hetero- 
karyon significantly affects the frequency of 5.1H 11  expres- 
sion at early time points. In fact, except for the  1.5-h  time 
point,  the  rate of 5.1Hll  accumulation  is significantly re- 
duced for bilaterally bordered nuclei relative to unilaterally 
bordered nuclei. This is not due to the fact that the products 
of unilaterally bordered nuclei are more readily detected due 
to limited diffusion and less rapid dilution over the surface of 
the membrane. First,  unilaterally bordered nuclei were fre- 
quently positioned in the center of the myotube, rather than 
at a distal end. Second, as described above, when two or more 
muscle nuclei are present in a heterokaryon, the 5.1HI 1 gene 
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Figure  4.  Effect  of nonmuscle nuclear  position  on  expression  of 
5.1H 11. Heterokaryons with only one nonmuscle nucleus and differ- 
ent  numbers of muscle nuclei were  grouped  according to  nuclear 
position:  nonmuscle bordered  bilaterally  or  unilaterally by  muscle 
nuclei. The expression of 5.1H 11 was analyzed on different days after 
fusion. The number of heterokaryons analyzed was 307 unilaterally 
bordered and 205 bilaterally bordered,  The rate of accumulation of 
5.1HII  for  bilaterally  bordered  nuclei  (0)  is  slower  than  that  of 
unilaterally bordered nuclei (©) at early time points. The mean values 
_+ standard error of the proportion (see Materials and Methods) are 
shown at each time point. Where error bars do not overlap, differences 
are significant at the 0.05 level using a two-sample Student's t test. 
Table L  Influence  of  Nuclear Number and Nuclear Ratio on Kinetics of Gene Expression 
Absolute number of nuclei  Ratio of nuclei 
(Total:  4 nuclei)  (Total:  2 to 20 nuclei) 
Muscle +  Heterokaryons  Muscle:non-  Heterokaryons 
nonmuscle  scored  t~o-  muscle  scored  /50" 
n  n 
A.  Equivalent  2 +  2  154  40  1:1  953  38 
B.  Excess muscle  3 +  1  127  48  3:1  206  47 
C.  Excess nonmuscle  1 +  3  109  52  1:3  149  55 
* The t~o values (time in hours required for 50% of heterokaryons of a given nuclear composition to express 5.1H 11) were calculated from computer-derived curves 
(see Materials and Methods). The kinetics of expression of 5.1H 11 did not differ significantly between heterokaryons grouped according to absolute number and 
ratio of nuclei. However, for each group the values in A differed significantly from those in B and C (P < 0.05). 
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spective of nuclear position. 
Discussion 
In the studies presented here, we report that gene dosage does 
not  affect  the  high  ultimate  potential  for gene  activation 
(>75%), but markedly affects the kinetics of expression of a 
eukaryotic gene characteristic of muscle. This kind of kinetic 
analysis of differentiation-specific gene expression as a func- 
tion of gene dosage or nuclear ratio has not been previously 
demonstrated  in  mammalian cells.  The  present  study  was 
made possible by the development of single  cell  assays for 
nuclear identification and gene expression and their applica- 
tion  to  an  analysis of stable  fusion  products in  which  the 
entire chromosome complement and cytoplasm of each cell 
type remains present for up to 2 wk. The findings are unex- 
pected. The rate of expression is relatively fast in heterokar- 
yons with equal or near-equal numbers of nuclei (1:1 or 2:1) 
and slower when the relative number of either nonmuscle or 
muscle nuclei is increased (1 :>2 and >2:1). The results have 
proved consistent for heterokaryons containing three different 
strains of human fibroblasts derived from fetal lung and from 
fetal and adult skin (Pavlath, G. K., C.-P. Chiu, and H. M. 
Blau, manuscript in preparation). The kinetics are not affected 
by heterokaryon size, but are affected by the position of the 
nonmuscle nucleus relative to muscle nuclei within  hetero- 
karyons. A limitation of this analysis is that the gene product 
studied  was  a  cell  surface  antigen.  Accumulation  of this 
antigen could be affected by transcription, translation,  and 
subsequent processing steps. However, our results may well 
reflect a gene dosage relationship at the transcriptional level; 
in other studies of gene expression in mass cultures of heter- 
okaryons,  the  kinetics  of accumulation  of the  cell  surface 
antigen 5.1H 11 and of transcripts of the a-cardiac actin gene 
were similar (Pavlath, G.  K.,  C.-P.  Chiu,  and  H. M.  Blau, 
manuscript  in  discussed  below,  our  results are  compatible 
with the following hypothesis: muscle gene expression is finely 
controlled  by  the  concentration  of trans-acting regulatory 
molecules. 
Human muscle gene expression is detected in  heterokar- 
yons in which the nonmuscle nuclei greatly outnumber the 
muscle nuclei.  Even in heterokaryons in which the ratio of 
mouse muscle to human fibroblast nuclei is  1:6, the expres- 
sion  of the  human  muscle  antigen,  5.1Hll,  is  observed. 
However, the rate of accumulation of gene products in these 
heterokaryons is consistently slower than that in heterokar- 
yons containing equal numbers of both types of nuclei. This 
kinetic difference suggests  that in heterokaryons with an in- 
creased number of nonmuscle nuclei, trans-acting regulatory 
molecules are limiting, because they must be shared. Increased 
time is required either for the limited number of molecules 
to find their appropriate binding sites or for the synthesis and 
accumulation  of the  requisite  number of molecules.  These 
molecules must be activators or de-repressors. Accordingly, a 
previously proposed model for differential gene expression in 
the development of phenotypes which is based solely on an 
irreversible repression  of genes (5)  cannot  account  for our 
findings. We conclude that one muscle nucleus can produce 
sufficient  amounts  of regulatory  molecules to  activate the 
5.1H11  gene(s) in one or more nonmuscle nucleus and that 
the time required for gene expression depends on the concen- 
tration of these molecules. 
Most  surprising  is  the  finding  that  when  muscle  nuclei 
outnumber fibroblast nuclei, the rate of 5.1H l 1 accumulation 
is consistently slower than when both are present in  equal 
numbers. This is contrary to expectation, since the greater the 
proportion  of muscle  nuclei  in  a  heterokaryon,  the  more 
genes  coding  for  trans-acting regulatory  molecules.  This 
should lead to an increase in the concentration of molecules 
per cell and a consequent increase in the rate of accumulation 
ofgene products. Alternatively, it is possible that the amount 
of regulatory factor per nucleus is reduced in heterokaryons 
containing an increased number of muscle nuclei  due to a 
decrease  in  factor  production  during  differentiation.  As  a 
result, more time would be required for a limited number of 
molecules to find their target sites. It is also possible that the 
results with increased muscle nuclei are due to a requirement 
for two different trans-acting regulatory factors, one contrib- 
uted  by each of the  two  fused cell  types. Accordingly, the 
nonmuscle cell might provide a factor that is necessary for its 
nucleus to respond to the muscle-activating factor. This would 
explain why the most rapid kinetics are observed when the 
stoichiometry or  nuclear  input  from the  two  cell  types is 
equivalent and balanced.  Finally, it is theoretically possible 
that an increased concentration  of regulatory factors could 
result in a slower accumulation of muscle gene products. This 
possibility is supported by the  data presented in  Fig.  4,  in 
which it is shown that the rate of 5.1H 11 expression at early 
time points is slower when  nonmuscle nuclei  are bordered 
bilaterally by muscle nuclei than when they are unilaterally 
bordered. Accordingly, nonmuscle nuclei that are flanked on 
both  sides  by  muscle  nuclei  might  be  exposed  to  higher 
concentrations of regulatory factors that are inhibitory.  An 
inhibition of transcription would occur if the factors bound 
to multiple sites with different affinities and ultimate effects 
on gene expression. These different possibilities will soon be 
directly testable. Given the evidence described below, we find 
this last hypothesis most appealing. 
In other systems, trans-acting regulatory molecules affect 
gene expression  in  a  dose-dependent  manner and  in  some 
cases have opposite effects at different concentrations. The T- 
antigen of SV40 and the repressor of bacteriophage lambda 
accumulate to a threshold concentration and bind to specific 
DNA  sites  with  different  effects (16,  17,  19,  24,  25).  The 
sequence of binding and ultimate effect on gene expression is 
the consequence of cooperative interactions as well as differ- 
ential affinities of the molecules for DNA sites. Of particular 
interest are lambda repressor and the E1A products of ade- 
novirus-2,  which  at  different  concentrations  act  either  as 
positive or negative regulators of gene transcription  (3,  16, 
19). In eukaryotes, concentration-dependent effects of regu- 
latory factors on  gene  expression have also  been  reported. 
Gene  dosage  affects the  synthesis  of proteins  required  for 
phosphate utilization  in Neurospora heterokaryons (15).  In 
rat hepatoma cells, multiple glucocorticoid hormone-receptor 
complexes regulate the rate of murine mammary tumor virus 
transcription in vivo by binding to several distinct enhancer 
sequences, possibly with different consequences (Yamamoto, 
K.,  personal  communication).  The  change  from  oocyte to 
somatic gene expression during Xenopus development is due 
to a combination of differential affinity for these genes for a 
40-kD transcription factor and of a marked decrease in factor 
concentration (29,  30). 
129  Pavlath and Blau Gene Dosage and Kinetics of  Muscle Gene Expression Our analyses of the effects ofgene dosage on muscle antigen 
expression  in  heterokaryons suggest  that the  expression  of 
muscle genes is also modulated by the concentration of trans- 
acting factors.  A  threshold concentration is required  but at 
high  concentrations  the  factors  may  be  inhibitory.  These 
results suggest that the differential  control of gene expression 
underlying cell specialization in eukaryotes, like the examples 
cited above, may be regulated  by a combination of changes 
in  factor concentration and binding affinity to  related  but 
distinct DNA sequences with different  functions. 
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